Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How has the diabetes care market size changed in recent years, and what is the outlook ahead?
The diabetes care market size has grown strongly in recent years. It will grow from $26.79 billion in 2024 to $29.25 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to rising obesity rates, growing demand for continuous monitoring devices, growing investment in diabetes research and development, and rising demand for personalized diabetes care.
The diabetes care market size is expected to see strong growth in the next few years. It will grow to $41.21 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing prevalence of diabetes, a growing geriatric population, rising awareness of diabetes management, and increasing healthcare access in developing regions. Major trends in the forecast period include technological advancements in diabetes monitoring, integration of artificial intelligence (AI) in diabetes care, advancements in insulin delivery systems, and development of smart insulin devices.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24206&type=smp
What are the top economic and technological drivers pushing diabetes care market growth?
The increasing obesity rates are expected to propel the growth of the diabetes care market going forward. Obesity rates refer to the percentage of a population with a body mass index (BMI) of 30 or higher, indicating obesity. The increasing obesity rates are due to a growing reliance on sedentary lifestyles, coupled with the widespread availability and consumption of highly processed, calorie-dense foods that are often low in nutritional value, contributing to an imbalance between calorie intake and physical activity. Diabetes care plays a crucial role in addressing rising obesity rates by promoting healthier lifestyle choices, improving glucose management, and encouraging weight control through advanced treatments such as insulin therapy and continuous glucose monitoring systems. For instance, in March 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, in 2022, 390 million adults were underweight, while 2.5 billion adults were overweight, including 890 million individuals considered obese. Therefore, the increasing obesity rates are driving the growth of the diabetes care market.
How is the diabetes care market segmented by product, application, and end-user?
The diabetes care market covered in this report is segmented –
1) By Product Type: Glucose Monitoring Devices, Insulin Pumps, Other Product Types
2) By Diabetes Type: Type 2 Diabetes, Type 1 Diabetes, Other Diabetes Type
3) By End User: Hospitals And Clinics, Homecare Settings, Ambulatory Care Settings, Other End Users
Subsegments
1) By Glucose Monitoring Devices: Blood glucose monitoring (BGM), Continuous glucose monitoring (CGM), Flash glucose monitoring (FGM)
2) By Insulin Pumps: Patch pump, Tethered pump, Implanted insulin pump
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/diabetes-care-global-market-report
What evolving trends are creating new opportunities in the diabetes care market?
Major companies operating in the diabetes care market are focusing on developing innovative technologies, such as automated insulin delivery (AID) systems, to improve glucose management by integrating continuous glucose monitoring (CGM) systems with insulin pumps for real-time adjustments. An Automated Insulin Delivery (AID) system is a technology that combines a Continuous Glucose Monitor (CGM) with an insulin pump to automatically adjust insulin delivery based on real-time glucose levels for improved diabetes management. For instance, in February 2024, Tandem Diabetes Care Inc., a US-based manufacturer of medical equipment for diabetes treatment, introduced the Tandem Mobi, the smallest and most robust automated insulin administration device for diabetics in the world. This innovative device offers a discreet, tubed insulin pump that is fully controllable via a smartphone app, giving users the freedom to manage their diabetes without the need for a traditional handheld controller. The Tandem Mobi is waterproof and rechargeable, and it integrates with Dexcom’s continuous glucose monitoring (CGM) system to automate insulin delivery using Tandem’s proven Control-IQ technology.
Which leading companies are dominating the diabetes care market landscape?
Major companies operating in the diabetes care market are F. Hoffmann-La Roche Ltd., Sanofi S.A., Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim Pharmaceuticals Inc., Terumo Corporation, Dexcom Inc., Dr. Reddy’s Laboratories Limited, SD Biosensor Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifeScan Inc., Ypsomed AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Bionime Corporation, Arkray Inc., ACON Laboratories Inc., ViCentra B.V., Microtech Medical Ltd., Sinocare Inc., MicroGene Diagnostic Systems Pvt. Ltd.
Which geographic areas are expected to offer the highest growth opportunities in thediabetes care market?
North America was the largest region in the diabetes care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Diabetes Care Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24206&type=smp
Need Customized Data On Diabetes Care Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24206&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
